Please log in to view this page
Username
Password
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
